353 related articles for article (PubMed ID: 24596721)
41. Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the National Cancer Data Base from 1998 to 2011.
Al-Hamadani M; Habermann TM; Cerhan JR; Macon WR; Maurer MJ; Go RS
Am J Hematol; 2015 Sep; 90(9):790-5. PubMed ID: 26096944
[TBL] [Abstract][Full Text] [Related]
42. Malignant lymphoma in northern Iraq: a retrospective analysis of 270 cases according to the World Health Organization classification.
Yaqo RT; Hughson MD; Sulayvani FK; Al-Allawi NA
Indian J Cancer; 2011; 48(4):446-51. PubMed ID: 22293258
[TBL] [Abstract][Full Text] [Related]
43. Combined applications of fine needle aspiration cytology and flow cytometric immunphenotyping for diagnosis and classification of non Hodgkin lymphoma.
Dey P; Amir T; Al Jassar A; Al Shemmari S; Jogai S; Bhat M G; Al Quallaf A; Al Shammari Z
Cytojournal; 2006 Oct; 3():24. PubMed ID: 17069647
[TBL] [Abstract][Full Text] [Related]
44. Primary diagnosis and REAL/WHO classification of non-Hodgkin's lymphoma by fine-needle aspiration: cytomorphologic and immunophenotypic approach.
Mourad WA; Tulbah A; Shoukri M; Al Dayel F; Akhtar M; Ali MA; Hainau B; Martin J
Diagn Cytopathol; 2003 Apr; 28(4):191-5. PubMed ID: 12672094
[TBL] [Abstract][Full Text] [Related]
45. Correlation of immunophenotype of sinonasal non-Hodgkin's lymphoma to Epstein-Barr virus infection.
Feng YF; Wu QL; Zong YS
Ai Zheng; 2007 Nov; 26(11):1170-6. PubMed ID: 17991313
[TBL] [Abstract][Full Text] [Related]
46. Childhood non-Hodgkin's lymphoma: an immunophenotypic analysis.
Shah SH; Muzaffar S; Pervez S; Hassan SH
J Pak Med Assoc; 2000 Mar; 50(3):89-91. PubMed ID: 10795468
[TBL] [Abstract][Full Text] [Related]
47. Non-Hodgkin's lymphoma by immunohistochemistry.
Akhter A; Saleheen MS; Hussain M; Majid N; Rahman MR; Shermin S; Rajib RC; Huda MM; Haque N
Mymensingh Med J; 2015 Jan; 24(1):108-14. PubMed ID: 25725676
[TBL] [Abstract][Full Text] [Related]
48. Splenic lymphoproliferative disorders in human T lymphotropic virus type-I endemic area of japan: clinicopathological, immunohistochemical and genetic analysis of 27 cases.
Kumagawa M; Suzumiya J; Ohshima K; Kanda M; Tamura K; Kikuchi M
Leuk Lymphoma; 2001 May; 41(5-6):593-605. PubMed ID: 11378577
[TBL] [Abstract][Full Text] [Related]
49. [Prevalence of lymphoma subtypes in Shanxi according to latest WHO classification].
Wang JF; Wang YZ; Chen ZW; Taylor RC
Zhonghua Bing Li Xue Za Zhi; 2006 Apr; 35(4):218-23. PubMed ID: 16776979
[TBL] [Abstract][Full Text] [Related]
50. Flow cytometric immunophenotyping (FCI) of lymphoma: correlation with histopathology and immunohistochemistry.
El-Sayed AM; El-Borai MH; Bahnassy AA; El-Gerzawi SM
Diagn Pathol; 2008 Nov; 3():43. PubMed ID: 18986555
[TBL] [Abstract][Full Text] [Related]
51. Clinical analysis of 670 cases in two trials of the European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group subtyped according to the Revised European-American Classification of Lymphoid Neoplasms: a comparison with the Working Formulation.
Pittaluga S; Bijnens L; Teodorovic I; Hagenbeek A; Meerwaldt JH; Somers R; Thomas J; Noordijk EM; De Wolf-Peeters C
Blood; 1996 May; 87(10):4358-67. PubMed ID: 8639796
[TBL] [Abstract][Full Text] [Related]
52. Lymphoma subtypes in India: a tertiary care center review.
Jain S; Lone MR; Goswami A; Mandal T; Panda AK; Ramteke P; Srivastav T; Sharma MC; Gogia A; Sharma A; Bakhshi S; Mahapatra M; Kumar L; Mallick S
Clin Exp Med; 2021 May; 21(2):315-321. PubMed ID: 33481141
[TBL] [Abstract][Full Text] [Related]
53. Non-Hodgkin's lymphoma.
Smith MR
Curr Probl Cancer; 1996; 20(1):6-77. PubMed ID: 8919170
[TBL] [Abstract][Full Text] [Related]
54. Immunologic markers in non-Hodgkin's lymphoma.
Freedman AS; Nadler LM
Hematol Oncol Clin North Am; 1991 Oct; 5(5):871-89. PubMed ID: 1938759
[TBL] [Abstract][Full Text] [Related]
55. Non-Hodgkin's malignant lymphoma of the sinonasal tract--treatment outcome for 53 patients according to REAL classification.
Hatta C; Ogasawara H; Okita J; Kubota A; Ishida M; Sakagami M
Auris Nasus Larynx; 2001 Jan; 28(1):55-60. PubMed ID: 11137364
[TBL] [Abstract][Full Text] [Related]
56. Clusterin expression in malignant lymphomas: a survey of 266 cases.
Saffer H; Wahed A; Rassidakis GZ; Medeiros LJ
Mod Pathol; 2002 Nov; 15(11):1221-6. PubMed ID: 12429802
[TBL] [Abstract][Full Text] [Related]
57. Host ethnicity influences non-Hodgkin's lymphoma subtype frequency and Epstein-Barr virus association rate: the experience of a multi-ethnic patient population in Malaysia.
Peh SC
Histopathology; 2001 May; 38(5):458-65. PubMed ID: 11422484
[TBL] [Abstract][Full Text] [Related]
58. The clinicopathological analysis of 303 cases with malignant lymphoma classified according to the World Health Organization classification system in a single institute of Taiwan.
Chen WL; Tsai WC; Chao TY; Sheu LF; Chou JM; Kao WY; Chen YC; Ho CL
Ann Hematol; 2010 Jun; 89(6):553-62. PubMed ID: 20012434
[TBL] [Abstract][Full Text] [Related]
59. Serous effusions in malignant lymphomas: a review.
Das DK
Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
[TBL] [Abstract][Full Text] [Related]
60. [NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphomas in children and adolescents. Part 1: Classification and allocation to strategic therapy groups. BIF study group].
Reiter A; Tiemann M; Ludwig WD; Wacker HH; Yakisan E; Schrappe M; Henzler D; Sykora KW; Brandt A; Odenwald E
Klin Padiatr; 1994; 206(4):222-33. PubMed ID: 7967418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
